SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001501134-23-000058
Filing Date
2023-07-05
Accepted
2023-07-05 16:53:53
Documents
14
Period of Report
2023-06-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nvta-20230630.htm   iXBRL 8-K 35175
2 EX-10.1 exhibit101toformxconsultin.htm EX-10.1 80139
6 nvta-20230630_g1.jpg GRAPHIC 36208
  Complete submission text file 0001501134-23-000058.txt   351268

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nvta-20230630.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nvta-20230630_lab.xml EX-101.LAB 23834
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nvta-20230630_pre.xml EX-101.PRE 12508
8 EXTRACTED XBRL INSTANCE DOCUMENT nvta-20230630_htm.xml XML 4104
Mailing Address 1400 16TH STREET SAN FRANCISCO CA 94103
Business Address 1400 16TH STREET SAN FRANCISCO CA 94103 (415) 374-7782
Invitae Corp (Filer) CIK: 0001501134 (see all company filings)

IRS No.: 271701898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36847 | Film No.: 231070090
SIC: 8071 Services-Medical Laboratories